| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.06 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.066 | 0.07 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | -0.067 | 0.07 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | 0.07 | 0.07 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | 0.059 | 0.07 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.07 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | 0.065 | 0.07 |
| mRNA | JQ-1:vorinostat (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.06 | 0.07 |
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | 0.064 | 0.07 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.07 |